chlorpheniramine has been researched along with emedastine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleisch, JH; Haisch, KD; Rinkema, LE; Whitesitt, CA | 1 |
Rinkema, LE; Silbaugh, SA; Stengel, PW | 1 |
Fukuda, T; Ito, K; Saito, T | 1 |
3 other study(ies) available for chlorpheniramine and emedastine
Article | Year |
---|---|
Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.
Topics: Animals; Benzhydryl Compounds; Benzimidazoles; Bronchial Provocation Tests; Chlorpheniramine; Diphenhydramine; Guinea Pigs; Histamine H1 Antagonists; Lung; Male; Muscle, Smooth; Promethazine; Pyrilamine; Terfenadine; Triprolidine | 1987 |
Pulmonary aerosol actions of LY188695 (KB2413), a new potent H1-receptor antagonist.
Topics: Aerosols; Airway Obstruction; Animals; Atropine; Benzimidazoles; Bronchial Provocation Tests; Bronchodilator Agents; Chlorpheniramine; Clemastine; Guinea Pigs; Histamine; Histamine H1 Antagonists; Injections, Intravenous; Male; Methacholine Chloride; Methacholine Compounds | 1987 |
Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic.
Topics: Airway Resistance; Anaphylaxis; Animals; Asthma; Benzimidazoles; Chlorpheniramine; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Respiration; Time Factors | 1984 |